BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2014

Position Statistics

Total Positions 79
New Positions 10
Increased Positions 37
Decreased Positions 25
Positions with Activity 62
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,270

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.63%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.27%
Healthcare 87.11%
Services 0%
Technology
Transportation
Utilities

79 Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
UNIVERSAL AMERN CORP NEW COM 16,071 -1,341 (7.7) 1,735,553
SALIX PHARMACEUTICALS INC COM 15,720 15,720 New 100,000
DERMA SCIENCES INC COM PAR $.01 14,706 257 1.78 1,856,877
ATRICURE INC COM 14,602 -1,768 (10.8) 825,902
DYNAVAX TECHNOLOGIES CORP COM NEW 13,482 New 766,010
DISCOVERY LABORATORIES INC NEW COM NEW 12,986 New 8,066,000
CONMED CORP COM 12,825 5,130 66.67 250,000
ANTARES PHARMA INC COM 12,267 2,610 27.03 4,700,000
CORIUM INTL INC COM 12,018 2,330 24.05 1,736,736
SYNERON MEDICAL LTD ORD SHS 11,862 New 1,005,221
IGI LABS INC COM 11,230 -1,843 (14.1) 974,810
LIGAND PHARMACEUTICALS INC COM NEW 10,959 10,959 New 199,000
ZOGENIX INC COM 10,479 1,008 10.64 6,237,645
ELEVEN BIOTHERAPEUTICS INC COM 10,217 1,151 12.70 966,615
CEMPRA INC COM 9,427 -22,208 (70.2) 284,625
FLEXION THERAPEUTICS INC COM 9,425 4,562 93.81 413,204
CATALYST PHARM PARTNERS INC COM 9,024 3,760 71.43 2,400,000
ANTHERA PHARMACEUTICALS INC COM NEW 9,008 2,435 37.05 1,783,812
XENCOR INC COM 8,126 -3,632 (30.89) 520,881
MEDGENICS INC COM NEW 8,036 8,036 New 1,025,000